Daiichi Sankyo
Karen Frantz has experience working in regulatory affairs and submission planning in the pharmaceutical industry. Karen is currently serving as the Senior Director of Regulatory Operations at Daiichi Sankyo since 2020. Prior to that, they worked at GlaxoSmithKline as the Manager of Submission Planning for Vaccines from 2005 to 2009. Before joining GlaxoSmithKline, Karen worked at GE Healthcare as the Manager of Regulatory Affairs from 2004 to 2005. Karen began their career in 2000 at Bristol-Myers Squibb as a Senior Regulatory Associate, where they worked until 2004.
Karen Frantz attended Washington College from 1991 to 1995, where they earned a Bachelor of Science degree in Biology.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.